Insurance coverage, out-of-pocket costs, benefits, billing, and access-related changes.
CMS’ mid-July 2026 notice clarifies the federal Independent Dispute Resolution (IDR) administrative fee for certain No Surprises Act disputes. For disputes initiated on or after June 11, 2026, the federal IDR fee is $15 per party per dispute—plus practical steps if you receive a bill that looks like a surprise bill.
CMS began enforcing updated hospital price transparency requirements on April 1, 2026. Here’s how to use the posted data for planning—and why it still can’t predict your exact out-of-pocket cost.
CMS enforcement of updated hospital price transparency requirements starts April 1, 2026. Here’s what hospitals must post, what “standard charges” mean, what they don’t tell you about your bill, and how to use the files for scheduled care.
If your ACA insurer says it will not offer your plan in 2027, your current coverage usually lasts through the end of 2026 unless your notice says otherwise. But HealthCare.gov shoppers may have less time than they expect to actively choose new 2027 coverage: November 1 through December 15, 2026.
For some adults affected by the new Medicaid work requirement, losing Medicaid does not automatically mean they can get subsidized ACA Marketplace coverage.
CMS has issued an interim final Medicaid work rule for 2027. Here is who it may affect, which exemptions may apply, and what to do before state notices arrive.
CMS issued a new interim final rule on June 1, 2026, setting a January 1, 2027 start for Medicaid community-engagement requirements in many states. The policy could affect some adults ages 19 to 64 and may create paperwork and renewal hurdles that vary by state.
CMS began enforcing updated hospital price-transparency rules on April 1, 2026. The goal is to make hospital pricing files more usable for patients and shoppers, but it does not remove every source of surprise billing or confusion. Here’s what changed, what CMS says it may improve, and what readers should still check before non-emergency hospital care.
CMS is proposing new prior-authorization rules for drugs that could shorten waits, improve denial notices, and expand electronic processing across Medicare Advantage, Medicaid, CHIP, and federally facilitated ACA marketplace plans. Some changes are already in motion, but the drug-related requirements would not take effect until 2027 unless CMS finalizes and implements the rule.
High U.S. prescription drug costs are driven by a lack of price regulation, patent monopolies, and complex supply chain mechanics involving pharmacy benefit managers (PBMs) that incentivize high list prices. Infographics highlight that these factors, combined with extensive marketing spend over R&D, lead to soaring launch prices and increased patient cost-related non-adherence.
CMS has proposed new rules that would push more drug prior authorizations into electronic workflows and set tighter decision timelines for several federally regulated health plans. If finalized, the changes could affect Medicare Advantage, Medicaid, CHIP, and ACA Marketplace plans, but details would still vary by plan and state.
CMS began enforcing updated hospital price transparency requirements on April 1, 2026. The rule is meant to make hospital pricing files and shoppable-service estimates easier to find and more useful, but it does not guarantee a simple or lower bill.
Federal vaccine recommendation wording can shape no-cost coverage. Here’s how private plans, Medicaid, Medicare, and VFC may differ in 2026.
CMS says it began enforcing updated hospital price transparency rules on April 1, 2026, but patients should still treat posted prices as a starting point.
Original Medicare can pay for some hearing tests in 2026, but hearing aids are still usually excluded. Here is what changed, what did not, and what to compare.
As of April 1, 2026, CMS is enforcing updated hospital price transparency rules. The files may be easier to compare, but they still are not your final bill.
CMS says 23.1 million people picked 2026 Marketplace coverage, but many moved to bronze plans that cut monthly premiums while raising deductibles and risk.
A new Medicare study suggests the $35 insulin cap is lowering patients’ costs. But supplies, other diabetes expenses, and gaps outside Medicare still matter.
A new CMS proposal could close a pathway for states to add adult dental benefits to ACA Marketplace plans in 2027, leaving many shoppers with separate coverage.
A January 2026 federal update makes HPV-only screening the preferred option for many women 30 to 65 and adds self-collection as a choice.
FDA approved the first generic Flovent HFA, but access may still depend on strength, pharmacy supply, insurance coverage, and safe switching.
ACA Marketplace coverage in 2026 may require more paperwork, closer plan shopping, and higher premiums for some after extra tax-credit savings ended on Dec. 31, 2025.
End of content
End of content
